Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
about
Involvement of B cells in non-infectious uveitisIdentification of OprF as a complement component C3 binding acceptor molecule on the surface of Pseudomonas aeruginosaCharacterization of intraocular immunopathology following intracameral inoculation with alloantigen.Increase in complement iC3b is associated with anti-inflammatory cytokine expression during late pregnancy in miceIndirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins.Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization.Interleukin-12: an update on its immunological activities, signaling and regulation of gene expressionDevelopment of non-viral vehicles for targeted gene transfer into microglia via the integrin receptor CD11b.Mice lacking C1q or C3 show accelerated rejection of minor H disparate skin grafts and resistance to induction of toleranceComplement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3Acquisition and presentation of follicular dendritic cell-bound antigen by lymph node-resident dendritic cellsCR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independentMechanisms of immune privilege in the posterior eye.Inhibition of complement alternative pathway suppresses experimental autoimmune anterior uveitis by modulating T cell responsesThree checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation.Effector mechanisms in transplant rejection.Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance.Neonatal plasma polarizes TLR4-mediated cytokine responses towards low IL-12p70 and high IL-10 production via distinct factorsThe apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic-cell immunostimulatory function.Immunomodulation to combat atherosclerosis: the potential role of immune regulatory cells.Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.The complement system plays a critical role in the development of experimental autoimmune anterior uveitis.Mac-1 Regulates IL-13 Activity in Macrophages by Directly Interacting with IL-13Rα1.Cutaneous Manifestations of Non-Celiac Gluten Sensitivity: Clinical Histological and Immunopathological FeaturesCD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiationOcular autoimmunity: the price of privilege?The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells.The role of complement and Toll-like receptors in organ transplantation.The role of complement in ocular pathology.ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and ThaiRole of NKT cells in anterior chamber-associated immune deviationAlternatively activated macrophages in infection and autoimmunity.Genetics of rheumatic disease.Fragile privileges: autoimmunity in brain and eyeComplement inhibition in cancer therapy.Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance.Innate immune mediators in cancer: between defense and resistance.Protection of host cells by complement regulators.The versatile functions of complement C3-derived ligands.Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism.
P2860
Q26766611-70C077F4-7988-4398-B013-1F4BE9FB9178Q28492950-B4C4D666-9D51-4AB6-802D-302A70680099Q33326826-8366CE6A-4D46-4900-8A59-94D567EAD701Q33728591-C06D83EF-EF7C-447B-B5EE-AFDF5146FDFAQ33822008-BB31B21A-A5ED-4AA5-866D-89FE91B45319Q33880596-73B3D7DD-8D7C-4071-B1E7-60F44669CEA6Q34248780-84305D73-3D30-4343-B422-9BC315CA6E23Q34312025-E2DDC01D-A09D-4AE2-B06E-6B44FC01E628Q34333956-9EB5DB29-6695-47B7-AC18-164AE519B15EQ34364911-D363AE23-8FA2-43EF-AA1D-D8BA76E30572Q34501458-AC5F7703-E1D0-41F3-80ED-679A346FA1CEQ34507790-6B9C231B-8BFB-482E-ACD0-9FAFDF295B72Q34566740-6DC32DBB-1614-4A17-B117-9CC33C0421C4Q34624453-450B34F5-576E-4B99-927A-260F9571A2BAQ34957062-3BD988E1-733E-45D3-AB27-F4B4D23A3982Q35583498-2B080A10-B04C-4C9E-926B-733A9FDCEF9CQ35745247-4BA55EE3-226E-4C37-97F3-89A20CA4CDE3Q35839858-DF41FCAE-6973-4C76-948D-EBE39870B744Q35849871-B7A03E1C-A101-4121-8CAE-81D1465D1C32Q35873748-EF974487-2015-4113-BB2A-D36B8DC83010Q35896708-F6E3AC0A-A713-4DD2-B5FC-37B3DE56E737Q35989062-F938999F-FB07-466F-AC3A-90D5BEB18A61Q36065128-82C1F12B-10FB-48DA-B744-30621206A736Q36102151-062AA147-B164-4F42-9BAD-E34EC73D0B50Q36229469-DF0765CF-F580-4830-9B92-DD8A0E6AA0CCQ36593726-79B27167-F770-4E87-A138-44D8D4EDBB10Q36666775-67C18EC8-4A08-45E5-A82F-6ADA22493A4AQ36817201-746C32CA-A961-456C-94B1-68DB2E84B1C8Q37094617-A9678C63-3841-4128-A176-83DF5A937040Q37183957-C306586D-9C22-4070-9896-F131E8ED234EQ37280696-5200699C-23D0-46F7-B75F-BCBA53FE605EQ37438259-7E0ED53B-75F2-4133-8BE6-0E719F61A6E7Q37453992-F0F68749-D0D8-4B83-88E8-1C144B75FC07Q37785483-A455D57B-B892-449A-8999-E77F2B649089Q38109340-97A33803-A852-4E30-A0D7-1CA59B87879FQ38445344-178A2083-2804-4BAA-A040-D31375A2B5F1Q38991015-119AFC1A-23F3-47A8-A989-ADDCEFAE4861Q38991019-75568837-1439-40AE-B4F8-A39271B22F15Q38991076-A2C74313-CB63-4527-A245-DCB3ED97B15AQ39984665-D7D2BE61-1552-4339-9B11-9235C7DC274C
P2860
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
description
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Februar 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/02/01)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/02/01)
@nl
наукова стаття, опублікована в лютому 2003
@uk
مقالة علمية (نشرت في فبراير 2003)
@ar
name
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
@ast
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
@en
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
@nl
type
label
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
@ast
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
@en
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
@nl
prefLabel
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
@ast
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
@en
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
@nl
P2093
P2860
P356
P1433
P1476
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
@en
P2093
Hector Molina
Henry J. Kaplan
Hye-Jung Suk
Jeong-Hyeon Sohn
Nalini S. Bora
Puran S. Bora
P2860
P2888
P304
P356
10.1038/NM814
P407
P577
2003-02-01T00:00:00Z
P5875
P6179
1001471541